Literature DB >> 19655263

Requirement of the activity of hepatocyte growth factor activator inhibitor type 1 for the extracellular appearance of a transmembrane serine protease matriptase in monkey kidney COS-1 cells.

Yuka Miyake1, Satoshi Tsuzuki2, Makoto Yasumoto1, Tohru Fushiki2, Kuniyo Inouye3.   

Abstract

Hepatocyte growth factor activator inhibitor type I (HAI-1) is a membrane-bound, serine protease inhibitor with two protease-inhibitory domains (Kunitz domain I and II). HAI-1 is known as a physiological inhibitor of a membrane-bound serine protease, matriptase. Paradoxically, however, HAI-1 has been found to be required for the extracellular appearance of the protease in an expression system using a monkey kidney COS-1 cell line. In the present study, we show using COS-1 cells that co-expression of recombinant variants of HAI-1 with the inhibition activity toward matriptase, including a variant consisting only of Kunitz domain I (the domain responsible for inhibition of matriptase), allowed for the appearance of this protease in the conditioned medium, whereas that of the variants without the activity did not. These findings suggest that the inhibition activity toward matriptase is critical for the extracellular appearance of protease in COS-1 cells.

Keywords:  Extracellular occurrence of matriptase; Hepatocyte growth factor activator inhibitor type 1; Intracellular environments; Kunitz domain; Matriptase-inhibitory activity

Year:  2009        PMID: 19655263      PMCID: PMC2780547          DOI: 10.1007/s10616-009-9219-7

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  31 in total

1.  The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor.

Authors:  Michael D Oberst; Cicely A Williams; Robert B Dickson; Michael D Johnson; Chen-Yong Lin
Journal:  J Biol Chem       Date:  2003-05-08       Impact factor: 5.157

2.  Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.

Authors:  Roman Szabo; John P Hobson; Karin List; Alfredo Molinolo; Chen-Yong Lin; Thomas H Bugge
Journal:  J Biol Chem       Date:  2008-08-19       Impact factor: 5.157

3.  Role of the stem domain of matriptase in the interaction with its physiological inhibitor, hepatocyte growth factor activator inhibitor type I.

Authors:  Kenji Kojima; Satoshi Tsuzuki; Tohru Fushiki; Kuniyo Inouye
Journal:  J Biochem       Date:  2009-03-10       Impact factor: 3.387

4.  Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1.

Authors:  Kimitoshi Denda; Takeshi Shimomura; Toshiya Kawaguchi; Keiji Miyazawa; Naomi Kitamura
Journal:  J Biol Chem       Date:  2002-01-22       Impact factor: 5.157

5.  Multiple sites of proteolytic cleavage to release soluble forms of hepatocyte growth factor activator inhibitor type 1 from a transmembrane form.

Authors:  T Shimomura; K Denda; T Kawaguchi; K Matsumoto; K Miyazawa; N Kitamura
Journal:  J Biochem       Date:  1999-11       Impact factor: 3.387

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 7.  Zymogen activation, inhibition, and ectodomain shedding of matriptase.

Authors:  Chen-Yong Lin; I-Chu Tseng; Feng-Pai Chou; Sheng-Fang Su; Ya-Wen Chen; Michael D Johnson; Robert B Dickson
Journal:  Front Biosci       Date:  2008-01-01

8.  Inhibition of membrane-type serine protease 1/matriptase by natural and synthetic protease inhibitors.

Authors:  Yoshie Yamasaki; Shigeki Satomi; Nobuhito Murai; Satoshi Tsuzuki; Tohru Fushiki
Journal:  J Nutr Sci Vitaminol (Tokyo)       Date:  2003-02       Impact factor: 2.000

Review 9.  Matriptase-dependent cell surface proteolysis in epithelial development and pathogenesis.

Authors:  Thomas H Bugge; Karin List; Roman Szabo
Journal:  Front Biosci       Date:  2007-09-01

10.  Mutation G827R in matriptase causing autosomal recessive ichthyosis with hypotrichosis yields an inactive protease.

Authors:  Antoine Désilets; François Béliveau; Guillaume Vandal; François-Olivier McDuff; Pierre Lavigne; Richard Leduc
Journal:  J Biol Chem       Date:  2008-02-08       Impact factor: 5.157

View more
  4 in total

1.  Roles of CUB and LDL receptor class A domain repeats of a transmembrane serine protease matriptase in its zymogen activation.

Authors:  Kuniyo Inouye; Marie Tomoishi; Makoto Yasumoto; Yuka Miyake; Kenji Kojima; Satoshi Tsuzuki; Tohru Fushiki
Journal:  J Biochem       Date:  2012-10-03       Impact factor: 3.387

2.  Identification of the matriptase second CUB domain as the secondary site for interaction with hepatocyte growth factor activator inhibitor type-1.

Authors:  Kuniyo Inouye; Satoshi Tsuzuki; Makoto Yasumoto; Kenji Kojima; Seiya Mochida; Tohru Fushiki
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

3.  Membrane-bound serine protease inhibitor HAI-1 is required for maintenance of intestinal epithelial integrity.

Authors:  Makiko Kawaguchi; Naoki Takeda; Shinri Hoshiko; Kenji Yorita; Takashi Baba; Akira Sawaguchi; Yuriko Nezu; Tsutomu Yoshikawa; Tsuyoshi Fukushima; Hiroaki Kataoka
Journal:  Am J Pathol       Date:  2011-08-12       Impact factor: 4.307

4.  The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.

Authors:  Stine Friis; Katiuchia Uzzun Sales; Jeffrey Martin Schafer; Lotte K Vogel; Hiroaki Kataoka; Thomas H Bugge
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.